138 related articles for article (PubMed ID: 35439002)
1. Novel Sphingosine Kinase 1 Inhibitor Suppresses Growth of Solid Tumor and Inhibits the Lung Metastasis of Triple-Negative Breast Cancer.
Zhang S; Chen X; Wu C; Xu H; Xie X; Feng M; Hu S; Bai H; Gao F; Tong L; Ding J; Liu H; Xie Z; Wang J
J Med Chem; 2022 Jun; 65(11):7697-7716. PubMed ID: 35439002
[TBL] [Abstract][Full Text] [Related]
2. Triple Negative Breast Cancer Depends on Sphingosine Kinase 1 (SphK1)/Sphingosine-1-Phosphate (S1P)/Sphingosine 1-Phosphate Receptor 3 (S1PR3)/Notch Signaling for Metastasis.
Wang S; Liang Y; Chang W; Hu B; Zhang Y
Med Sci Monit; 2018 Apr; 24():1912-1923. PubMed ID: 29605826
[TBL] [Abstract][Full Text] [Related]
3. Metastatic triple-negative breast cancer is dependent on SphKs/S1P signaling for growth and survival.
Maiti A; Takabe K; Hait NC
Cell Signal; 2017 Apr; 32():85-92. PubMed ID: 28108260
[TBL] [Abstract][Full Text] [Related]
4. Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1.
Schnute ME; McReynolds MD; Kasten T; Yates M; Jerome G; Rains JW; Hall T; Chrencik J; Kraus M; Cronin CN; Saabye M; Highkin MK; Broadus R; Ogawa S; Cukyne K; Zawadzke LE; Peterkin V; Iyanar K; Scholten JA; Wendling J; Fujiwara H; Nemirovskiy O; Wittwer AJ; Nagiec MM
Biochem J; 2012 May; 444(1):79-88. PubMed ID: 22397330
[TBL] [Abstract][Full Text] [Related]
5. Sphingosine Kinase 1 Signaling Promotes Metastasis of Triple-Negative Breast Cancer.
Acharya S; Yao J; Li P; Zhang C; Lowery FJ; Zhang Q; Guo H; Qu J; Yang F; Wistuba II; Piwnica-Worms H; Sahin AA; Yu D
Cancer Res; 2019 Aug; 79(16):4211-4226. PubMed ID: 31239273
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer sphingosine-1-phosphate is associated with phospho-sphingosine kinase 1 and lymphatic metastasis.
Tsuchida J; Nagahashi M; Nakajima M; Moro K; Tatsuda K; Ramanathan R; Takabe K; Wakai T
J Surg Res; 2016 Sep; 205(1):85-94. PubMed ID: 27621003
[TBL] [Abstract][Full Text] [Related]
7. Sphingosine-1-phosphate/sphingosine kinase 1-dependent lymph node metastasis in esophageal squamous cell carcinoma.
Kawakita Y; Motoyama S; Sato Y; Koyota S; Wakita A; Liu J; Saito H; Minamiya Y
Surg Today; 2017 Nov; 47(11):1312-1320. PubMed ID: 28364399
[TBL] [Abstract][Full Text] [Related]
8. Targeting SPHK1/PBX1 Axis Induced Cell Cycle Arrest in Non-Small Cell Lung Cancer.
Lin Z; Li Y; Han X; Fu Z; Tian Z; Li C
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361531
[TBL] [Abstract][Full Text] [Related]
9. Role of Sphingosine Kinase 1 and S1P Transporter Spns2 in HGF-mediated Lamellipodia Formation in Lung Endothelium.
Fu P; Ebenezer DL; Berdyshev EV; Bronova IA; Shaaya M; Harijith A; Natarajan V
J Biol Chem; 2016 Dec; 291(53):27187-27203. PubMed ID: 27864331
[TBL] [Abstract][Full Text] [Related]
10. Cross-talk between LPA1 and epidermal growth factor receptors mediates up-regulation of sphingosine kinase 1 to promote gastric cancer cell motility and invasion.
Shida D; Fang X; Kordula T; Takabe K; Lépine S; Alvarez SE; Milstien S; Spiegel S
Cancer Res; 2008 Aug; 68(16):6569-77. PubMed ID: 18701480
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of SphK1 enhances cell proliferation and invasion in triple-negative breast cancer via the PI3K/AKT signaling pathway.
Li J; Song Z; Wang Y; Yin Y; Liu Y; Yuan R; Nan X
Tumour Biol; 2016 Aug; 37(8):10587-93. PubMed ID: 26857281
[TBL] [Abstract][Full Text] [Related]
12. Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis.
Nagahashi M; Ramachandran S; Kim EY; Allegood JC; Rashid OM; Yamada A; Zhao R; Milstien S; Zhou H; Spiegel S; Takabe K
Cancer Res; 2012 Feb; 72(3):726-35. PubMed ID: 22298596
[TBL] [Abstract][Full Text] [Related]
13. Sphingosine Kinase 1 and Sphingosine-1-Phosphate Signaling in Colorectal Cancer.
Bao Y; Guo Y; Zhang C; Fan F; Yang W
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 28991193
[TBL] [Abstract][Full Text] [Related]
14. The sphingosine kinase-1/sphingosine-1-phosphate axis in cancer: Potential target for anticancer therapy.
Zheng X; Li W; Ren L; Liu J; Pang X; Chen X; Kang D; Wang J; Du G
Pharmacol Ther; 2019 Mar; 195():85-99. PubMed ID: 30347210
[TBL] [Abstract][Full Text] [Related]
15. The Tumorigenic Effect of Sphingosine Kinase 1 and Its Potential Therapeutic Target.
Wang X; Sun Y; Peng X; Naqvi SMAS; Yang Y; Zhang J; Chen M; Chen Y; Chen H; Yan H; Wei G; Hong P; Lu Y
Cancer Control; 2020; 27(1):1073274820976664. PubMed ID: 33317322
[TBL] [Abstract][Full Text] [Related]
16. Sphingosine kinase 1 is required for TGF-β mediated fibroblastto- myofibroblast differentiation in ovarian cancer.
Beach JA; Aspuria PJ; Cheon DJ; Lawrenson K; Agadjanian H; Walsh CS; Karlan BY; Orsulic S
Oncotarget; 2016 Jan; 7(4):4167-82. PubMed ID: 26716409
[TBL] [Abstract][Full Text] [Related]
17. Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer.
Ruckhäberle E; Rody A; Engels K; Gaetje R; von Minckwitz G; Schiffmann S; Grösch S; Geisslinger G; Holtrich U; Karn T; Kaufmann M
Breast Cancer Res Treat; 2008 Nov; 112(1):41-52. PubMed ID: 18058224
[TBL] [Abstract][Full Text] [Related]
18. Relationship between Sphk1/S1P and microRNAs in human cancers.
Khoei SG; Sadeghi H; Samadi P; Najafi R; Saidijam M
Biotechnol Appl Biochem; 2021 Apr; 68(2):279-287. PubMed ID: 32275078
[TBL] [Abstract][Full Text] [Related]
19. Sphingosine kinase 1/sphingosine-1-phosphate regulates the expression of interleukin-17A in activated microglia in cerebral ischemia/reperfusion.
Lv M; Zhang D; Dai D; Zhang W; Zhang L
Inflamm Res; 2016 Jul; 65(7):551-62. PubMed ID: 27002656
[TBL] [Abstract][Full Text] [Related]
20. Ginsenoside compound K inhibits angiogenesis via regulation of sphingosine kinase-1 in human umbilical vein endothelial cells.
Shin KO; Seo CH; Cho HH; Oh S; Hong SP; Yoo HS; Hong JT; Oh KW; Lee YM
Arch Pharm Res; 2014; 37(9):1183-92. PubMed ID: 24687256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
